Alnylam Pharmaceuticals
Agent42Agent Readiness: 42/100. Above median. Measured by StartupHub.ai. Median 41.Trust85Data Trust: 85/100. Top 25%. Measured by StartupHub.ai. Median 61.Biopharmaceutical company pioneering RNA interference (RNAi) therapeutics to treat rare and prevalent genetic diseases.
About
Alnylam Pharmaceuticals is a commercial-stage biopharmaceutical company that develops innovative therapies based on RNA interference (RNAi). By silencing disease-causing genes at the genetic level, the company provides transformative treatments for patients with rare and common genetic, metabolic, and cardiovascular diseases.
Similar companies
Developing innovative gene therapies to preserve or restore vision in patients with retinal diseases.
Shares Biotechnology, Healthcare
Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.
Shares Healthcare
Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
In Biotech
Arrakis Therapeutics is a biopharmaceutical company developing oral medicines that target RNA to treat a range of diseases. The company is based in Waltham, Mas
In Biotech
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Pharmaceuticals
Biotechnology company developing and commercializing cell therapies for cancer treatment.
Shares Biotechnology, Pharmaceuticals
Key facts
- Website
- alnylam.com
- Headquarters
- Cambridge, Massachusetts, United States
- Founded
- 2002
- Business model
- B2B
Tech stack
Detected on alnylam.com, last scanned 20 Oct 2026. Run your own scan
- Frontend
- jQuery, Bootstrap
- Email provider
- Mimecast
Alnylam Pharmaceuticals scores 73. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Alnylam Pharmaceuticals trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Alnylam Pharmaceuticals is 85 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Alnylam Pharmaceuticals
